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Objective: This study was designed to evaluate the ability of autologous tissue-
engineered trachea shaped in a helix to form the structural component of a func-
tional tracheal replacement.
Methods: Nasal septum were harvested from six 2-month-old sheep. Chondrocytes
and fibroblasts were isolated from tissue and cultured in media for 2 weeks. Both
types of cells were seeded onto separate nonwoven meshes of polyglycolic acid. The
chondrocyte-seeded mesh was wound around a 20-mm-diameter  50-mm-long
helical template and then covered with the fibroblast-seeded mesh. In 2 separate
studies the implants were placed either in a subcutaneous pocket in the nude rat (rat
tissue-engineered trachea) or in the neck of a sheep (sheep tissue-engineered trachea).
Rat tissue-engineered tracheas were harvested after 8 weeks and analyzed by means of
histology and biochemistry. Sheep tissue-engineered tracheas were harvested from the
neck at 8 weeks and anastomosed into a 5-cm defect in the sheep trachea.
Results: Sheep receiving tissue-engineered trachea grafts survived for 2 to 7 days
after implantation. Gross morphology and tissue morphology were similar to that of
native tracheas. Hematoxylin-and-eosin staining of rat tissue-engineered tracheas
and sheep tissue-engineered tracheas revealed the presence of mature cartilage sur-
rounded by connective tissue. Safranin-O staining showed that rat tissue-engineered
tracheas and sheep tissue-engineered tracheas had similar morphologies to native
tracheal cartilage. Collagen, proteoglycan, and cell contents were similar to those seen
in native tracheal tissue in rat tissue-engineered tracheas. Collagen and cell contents of
sheep tissue-engineered tracheas were elevated compared with that of normal tracheas,
whereas proteoglycan content was less than that found in normal tracheas.
Conclusions: This study demonstrated the feasibility of recreating the cartilage and
fibrous portion of the trachea with autologous tissue harvested from single procedure.
This approach might provide a benefit to individuals needing tracheal resection.
Extensive tracheal reconstruction is often required in patients withbenign and malignant diseases. Several approaches for trachealreplacement have been described, including the use of autologoustissue,1 autografts,2,3 allografts,4 prosthetic materials,5,6 or a combi-nation of these approaches.7 These efforts have met with limitedsuccess because of stenosis, immunologic complications, bacterial
infections, and material failure. The limitations of synthetic tracheal replacement
have led to an interest in regeneration of tracheal tissue. Reconstruction of other
cartilaginous structures, such as the ear and nose, has been accomplished with tissue-
engineering techniques,8 but few studies have focused on reconstruction of cartilage in
the trachea. Tissue engineering endeavors to combine concepts from biology, funda-
mental engineering, and polymer chemistry to produce new tissue replacement materi-
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als. The reconstruction of the trachea according to biologic
principles makes it desirable to use autologous tissue meeting
the requirements of reliability, stability, and biocompatibility.
Previously, we demonstrated the replacement of resected rat
tracheas with a tube of tissue-engineered cartilage.9 One of the
main limitations in this approach is the specific mechanical
requirement placed on the trachea. The trachea must maintain
flexibility in the longitudinal direction to allow for free move-
ment of the head, while maintaining the rigidity necessary to
prevent collapse of the trachea during breathing. This is ac-
complished in native tissue by using the cartilaginous rings,
which are not adequately modeled by a cartilaginous tube. This
study was designed to evaluate the ability of autologous tissue-
engineered cartilage shaped in a helix to form the structural
component of a functional tracheal replacement.
Materials and Methods
Cell Isolation and Culture
Samples of sheep nasal septal cartilage (5  5 mm) were obtained
from six 2-month-old sheep (Figure 1). Connective tissue was
separated from the underlying cartilage. Chondrocytes were iso-
lated from cartilage by means of digestion in 0.3% collagenase type II
(Worthington Biochemical Corp) on a 37°C shaker for 5 to 8 hours.
The resulting cell suspension was passed through a 100-m cell
strainer (Becton Dickinson and Co). Fibroblasts were obtained from
connective tissue by means of culture of 2  2–mm explants.
Chondrocytes were cultured in Ham’s F-12 media (Gibco),
including 10% fetal calf serum (Gibco) with 292 g/mL L-glu-
tamine, 10,000 U/mL penicillin G, 10,000 U/mL streptomycin
sulfate, 25 g/mL amphotericin B, and 50 g/mL ascorbic acid for
2 weeks. Fibroblasts were cultured in Dulbecco’s modified Eagle’s
medium (Gibco), including 10% fetal bovine serum with L-glutamine
and antibiotic-antimycotic solution. Culture media were changed ev-
ery 3 days (Figure 2, A). After 2 weeks, once a confluent monolayer
was detected, chondrocytes and fibroblasts were harvested by means
of digestion with 0.05% trypsin–ethylenediamine tetraacetic acid
(EDTA; Gibco). The isolated cells were counted with a hemocytom-
eter, and their viability was determined with use of the trypan blue
(Sigma-Aldrich) exclusion method.
Cell Seeding and Implantation
Chondrocyte suspensions were concentrated at 50  106 cells/mL
and placed on a 100  10  2–mm nonwoven mesh of polygly-
colic acid (PGA) fibers (Davis & Geck; Figure 2, B). Similarly,
fibroblasts were concentrated at 25  106 cells/mL (Figure 2, C
and D) and seeded onto a 50  10–mm PGA mesh. The chon-
drocyte-seeded mesh was placed in the grooves of a 20-mm-
diameter  50-mm-long helical template made from a Silastic
ERTV mold-making kit (Dow Corning; Figure 3, A), and the entire
template was covered with the fibroblast-seeded mesh (Figure 3,
B). Two experimental models of tissue-engineered trachea (TET)
were designed.
For rat TETs (6 implants), the implants were placed in a
subcutaneous pocket in the dorsum of athymic rats, harvested, and
analyzed by means of histology and biochemistry. Tissue was
assayed for cartilage-specific extracellular matrix components, in-
cluding proteoglycans and collagen, as well as tissue cell density.
For sheep TETs (6 implants), each sheep was anesthetized with
ketamine (5 mg/kg) and xylazine (0.05-1 mg/kg), intubated endo-
tracheally, and administered isoflurane by means of a ventilator. A
longitudinal incision was made in the neck of the sheep just above
the sternocleidomastoid muscle. A pocket was created under this
muscle, and implants were derived from cells from each sheep in
Figure 1. Schematic diagram of methods for isolation, culture, and implantation.
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the pocket in corresponding sheep. After 8 weeks, each sheep was
anesthetized as described above. The autologous TET was har-
vested from the neck, and the cervical trachea was resected at 5 cm
in length. The lungs were ventilated by means of a second endo-
tracheal tube intubated through the operative field. The autologous
TET was implanted with end-to-end anastomoses by using 3-0
absorbable running sutures (Figure 4). Postoperatively, each
sheep was allowed to recover spontaneously. All animals re-
ceived humane care in compliance with the “Principles of
Laboratory Animals Care” formulated by the National Society
for Medical Research and the “Guide for the Care and Use of
Laboratory Animals” prepared by the National Academy of
Science and published by the National Institutes of Health
(publication No. 85-23, revised 1985). All animal procedures
Figure 2. Phase-contrast photomicrograph of sheep nasal chondrocytes in monolayer culture (A). (Original
magnification 200.) Nonwoven PGA mesh used for chondrocyte and fibroblast growth (B). Chondrocytes attaching
to PGA on day 0 (C) and growth of cells and matrix on day 7 (D).
Figure 3. A, Helical template fabricated with a silicone mold-making kit. B, The chondrocyte-seeded matrix was
placed in the grooves of the template (arrow), and the entire template was wrapped with the fibroblast-seeded
mesh.
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complied with the guidelines provided by the Institutional An-
imal Care and Use Committee of the University of Massachu-
setts Medical School.
Histologic Examinations
The specimens for histology were fixed in 10% phosphate-buff-
ered formation, embedded in paraffin, and sectioned. Sections
were stained with hematoxylin-and-eosin (H&E) and Safranin-O.
Biochemical Analysis
Biochemical analysis was performed on harvested tissue to
quantify the level of cartilage-specific extracellular matrix com-
ponents. Samples were digested by means of the addition of 1.0
mL of 100 mmol/L sodium phosphate, 10 mmol/L sodium
EDTA, 10 mmol/L cysteine hydrochloride (Sigma), 5 mmol/L
EDTA (BDH), and 125 g/mL papain (Sigma). The samples
were incubated at 60°C for 24 hours and stored at 20°C. The
sulfated glycosaminoglycan (GAG) content of digests was
quantified by means of previously described methods.10 In
brief, 10 L of papain digest was added to 200 L of 1,9-
dimethylmethylene blue dye at pH 3.0, with absorbencies de-
tected at 525 nm with a spectrophotometer immediately after
the addition of the dye. The GAG content of the samples was
determined by using a C-6-S from shark cartilage (Sigma) as a
standard. The hydroxyproline contents of digests were deter-
mined by using the procedure of Stegemann and Stalder.11 In
brief, the papain digests were hydrolyzed with equal volumes of
6N HCL in 115°C for 16 to 24 hours. Chloramine T and
p-dimethylamino-benzaldehyde were added to hydrolyzed sam-
ples, and absorbances were detected at 560 nm with a spectro-
photometer immediately after the addition of the dye. The DNA
content of samples was determined by quantitating the fluores-
cence (358/458 nm) of aliquots immediately after mixing with
bisbenzimidazole dye (Hoechst 33258) with a fluorimeter.12
TABLE 1. Postoperative course of the sheep undergoing
tracheal reconstruction with TETs
No.
Postoperative
survival period
Trachea status
at death
Sheep TET
condition
1 7 d Malacia Soft
2 5 d Malacia Soft
3 2 d Stenosis Small
4 2 d Stenosis Small
5 2 d Stenosis Small
6 2 d Stenosis Small
Figure 4. Implantation of TETs in sheep. A, A pocket was created under the sternocleidomastoid muscle, and the
implant was placed in this pocket. B, The autologous TET was harvested from the sheep neck at 8 weeks. C, A 5-cm
defect in the cervical trachea was created, and the lungs were ventilated with a second endotracheal tube
inserted through the operative field. D, The sheep TET was implanted by means of an end-to-end anastomosis.
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Results
Sheep receiving TETs breathed spontaneously with no sub-
cutaneous emphysema and were voluntarily ambulatory.
Animal survival time ranged from 2 to 7 days (Table 1).
Sheep with the longest survivals were killed as a result of
extensive tracheomalacia at day 7. Animals with the shortest
survivals were killed as a result of stenosis at day 2.
Gross Morphology
The gross appearance of the TET in both groups 1 and 2 was
very similar to that of native trachea. There is a distinct
structure containing both cartilage and connective tissue
that is similar to that seen in native trachea (Figures 4, B,
and 5).
Histology
On histologic examination, the engineered tracheal surfaces
of both groups were smooth, and formation of cartilage was
evident. H&E and Safranin-O stains demonstrated hyaline
cartilage closely resembling that of native tracheal cartilage,
with similar overall morphology. H&E staining revealed the
presence of mature cartilage surrounded by connective tis-
sue, as expected in native trachea. Safranin-O staining
showed that tissue-engineered cartilage was organized into
lobules with round, angular lacunae, each containing single
chondrocytes (Figure 6).
Biochemical Assay
Proteoglycan content of the rat TET was similar to that
found in native trachea. In the sheep TETs proteoglycan
contents were lower than that found in the native trachea
and in rat TETs (Figure 7).
The collagen content of both TETs was similar to that
found in the native trachea (Figure 8). Total tissue DNA
content was measured to quantify cell density. The cell
density in sheep TETs was higher than that in the native
trachea and rat TETs (Figure 9).
Discussion
A variety of materials have been used in tracheal prostheses,
such as various inert materials alone5,6 or in combination
with autologous tissue,7,13 but none of them has been effec-
tive. There is, however, a general agreement that autologous
tissues are the first choice in reconstructive surgery, partic-
ularly in tracheal surgery. Several reports have described
experimental tracheal reconstruction with autotransplants,
but none of them has proven to be satisfactory for human
use. However, this procedure is complicated by the need for
long-term immunosuppressant therapy and a lack of suffi-
cient donor tissue. Akl and colleagues14 and Osada and
Kojima15 reported experimental reconstruction of a tracheal
defect longer than 10 cm using a rotated main bronchus. The
major drawback of this method is loss of part of the lung,
and the method is also unable to be used for high medias-
tinal tracheal defects. Cavadas1 created a suitable native
trachea, which is composed of an autologous microvascular
jejunal transfer with a cartilage skeleton for major tracheal
reconstruction. This method is ideal but is complicated by
the need for a tracheal stent and the need for a 10- to 15-cm
jejunum with its vessels.
The goal of our study was to create a completely autol-
ogous TET structure composed of a cartilaginous frame-
work with connective tissue by using tissue harvested from
a single procedure. This has the potential benefit of facili-
tating an autologous approach for repair of segmental de-
Figure 5. Lateral view (A) and frontal view (B) of a TET harvested from a nude rat at 8 weeks. In both views
similarity to native tracheal tissue is evident. There is a distinct structure containing both cartilage and connective
tissue, just as in the normal trachea.
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fects. Gross morphology showed that the rat TET was
similar to the native trachea and had excellent flexibility.
In contrast, sheep TETs were much less stiff and
collapsed quite easily. This is consistent with the tracheo-
malacia observed in animals after anastomosis. The dif-
ference in stiffness between the rat TET and the sheep
TET was reflected in the biochemical analysis of these
tissues. Sheep TETs had a much lower GAG content than
rat TETs. GAG and hydroxyproline are reflective of
proteoglycan and collagen levels in these tissues. The
presence of GAG in the neomatrix provides quantitative
evidence of extracellular matrix production by chondro-
cytes seeded onto PGA. Because proteoglycans are the
major structural component of the cartilage extracellular
matrix responsible for tissue stiffness,16 it is logical that
the sheep TET should be less stiff as well. The mecha-
nism behind the decreased proteoglycan content in sheep
TETs is not clear, but it likely involves the inflammatory
response to the implant. PGA is known to elicit a strong
inflammatory response that can inhibit the formation of
tissue-engineered cartilage.17 This response is likely to
involve inflammatory mediators, such as interleukin 1
(IL-1). IL-1 specifically is known to induce a degradation
of cartilage that results in significant loss of tissue me-
chanical function.18 This process is thought to be medi-
ated by the IL-1–induced production of degradative en-
zyme that is known to alter the mechanical properties of
cartilage.19 Greater understanding of this process would
aid in the analysis and design of polymer-based tissue-
engineered implants, as well as in the understanding of
inflammatory-based diseases of the trachea.
In future studies we intend to construct and use a
larger diameter template for the helical portion of the
implant. This will compensate for the animal growth that
Figure 6. H&E staining: A, rat TET; B, sheep TET; C, native trachea. (Original magnification 100). Safranin-O stains
were deeply positive and indicative of abundant proteoglycan production in each group: D, rat TET; E, sheep TET;
F, native trachea.
Figure 7. GAG content of native and engineered tissue (data
represent n  6  SD). Statistical difference was determined by
means of 1-way analysis of variance.
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occurs between the initial implantation and anastomosis
and should prevent short-term stenosis after surgical in-
tervention. We will also investigate the use of alternative
materials as scaffolds for cartilage growth, such as algi-
nate and pluronic. These materials have been shown to be
favorable for cartilage growth in autologous models.
Furthermore, we plan to maintain the vascular supply to
the implant after anastomosis by preserving the surround-
ing muscle pedicle.
We thank Steve Carr, Carol Lovewell, and Gwenn Gaumon for
their expert technical assistance and for preparation of the exper-
iment.
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